Dysfunctional epidermal growth factor receptor kinase (EGFR) plays a role in tumour progression and angiogenesis in squamous cell carcinoma of the head and neck (SCCHN), non-small cell lung cancer (NSCLC) and colorectal cancer1,.2 The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.